Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Conditions

Diseases of the Cardiovascular System

Volunteers
Health Professionals

What is the purpose of this trial?

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with heart failure and reduced ejection fraction (HFrEF).

Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Trial with
Ancora Heart, Inc.
Start Date
04/30/2021
End Date
01/27/2025

For more information about this study, contact:

Arben Ademi

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Ryan Karl Kaple, MD, FACC, FSCAI
Assistant Professor; Associate Fellowship Program Director, Interventional Cardiology Program; Fellowship Program Director, Structural Heart Disease Program; Program Evaluation Committee, Interventional Cardiology Program; Director, Structural Heart Disease Program, Cardiology; Firm Chief - Cardiac Step-down, Cardiology

Sub-Investigators

Last Updated
11/17/2021
Study HIC
#2000028335

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information